Merck (NYSE:MRK) is approaching phase 2 data for Winrevair in pulmonary hypertension. Results will focus on the 6 minute walk ...

Higher blood levels of allergy molecule IgE were associated with worsening right heart function in people with PAH, a study ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

Data from BridgeBio Pharma’s Phase 3 FORTIFY study show that BBP-418 significantly increases levels of a key disease biomarker that helps stabilize muscles in patients with limb-girdle muscular ...

The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...

We cannot let alarm fatigue silence the response to Kennedy’s and Trump’s destruction,” writes Robert Shpiner.

Investor attention is fixed on a critical regulatory milestone for biopharmaceutical firm aTyr Pharma. The company is ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

People with PAH often have problems in the tiny blood vessels that deliver oxygen and nutrients to heart cells, according to a study.

St. Mary’s Medical Center, part of Marshall Health Network, is launching a new COPD Community Screening Program to help identify individuals who may be at risk for Chronic ...

Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises.